Dr. Yang Fan has nearly two decades of clinical and research experience in hematology and is recognized for her expertise in the precision diagnosis and comprehensive management of malignant hematologic diseases, including lymphoma, multiple myeloma, and acute leukemia. She has extensive hands-on experience in CAR-T cell therapy, as well as autologous and allogeneic hematopoietic stem cell transplantation (HSCT), and has managed numerous complex and high-risk cases throughout the full continuum of care.
Dr. Yang’s research focuses on integrated strategies combining CAR-T therapy with HSCT, mechanisms of immune escape in relapsed/refractory hematologic malignancies, post-transplant immune reconstitution and microenvironmental regulation, and predictive modeling for acute and chronic graft-versus-host disease (GVHD). She has led and participated in multiple clinical and translational research projects that have contributed valuable evidence to the advancement of high-level therapeutic strategies in hematologic oncology. Her research has been presented multiple times at major international conferences such as ASH, EHA, EBMT, and APBMT, reflecting her strong academic influence and international perspective in immunotherapy and transplantation for hematologic malignancies.
